Paper · 2023

RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway.

Linbo Zhu, Hong Shi, Pengfei Li, Pengbin Zhang

PubMed, 53(1), 21–29 · Published 1 January 2023

View at the publisherCite this paper

In brief

“RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway.” is a 2023 paper by Linbo Zhu and 3 co-authors, published in PubMed. OpenAlex counts 5 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
5
Most cited in
2026 (3)
Authors
4

Abstract

OBJECTIVE: Triple-negative breast cancer (TNBC) is a subtype with high invasiveness. Due to lacking specific and effective therapies, it is necessary to explore the mechanism of TNBC progression and search for new therapeutic targets. METHODS: biological function analyses including MTT assay, colony formation assay, wound-healing assay and Transwell assay were conducted to explore the role… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zhu, L., Shi, H., Li, P., & Zhang, P. (2023). RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway. PubMed, 53(1), 21–29. https://pubmed.ncbi.nlm.nih.gov/36889779

MLA 9

Zhu, Linbo, et al. “RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway.” PubMed, vol. 53, no. 1, 2023, pp. 21–29. https://pubmed.ncbi.nlm.nih.gov/36889779.

Chicago

Zhu, Linbo, Hong Shi, Pengfei Li, and Pengbin Zhang. 2023. “RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway.” PubMed 53 (1): 21–29. https://pubmed.ncbi.nlm.nih.gov/36889779.

Harvard

Zhu, L. et al. (2023) ‘RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway.’, PubMed, 53(1), pp. 21–29. Available at: https://pubmed.ncbi.nlm.nih.gov/36889779.

IEEE

L. Zhu, H. Shi, P. Li, and P. Zhang, “RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway.,” PubMed, vol. 53, no. 1, pp. 21–29, 2023.

BibTeX

@article{zhu2023suppressed,
  title     = {{RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway.}},
  author    = {Zhu, Linbo and Shi, Hong and Li, Pengfei and Zhang, Pengbin},
  journal   = {PubMed},
  year      = {2023},
  volume    = {53},
  number    = {1},
  pages     = {21--29},
  url       = {https://pubmed.ncbi.nlm.nih.gov/36889779}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer

  • RNF43
  • triple-negative breast cancer
  • Wnt/β-catenin signaling
  • epithelial-mesenchymal transition
  • tumor progression
  • cell proliferation
  • cell migration
  • tumor suppressor

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Zhu, L., Shi, H., Li, P., & Zhang, P. (2023). RNF43 Suppressed Triple-Negative Breast Cancer Progression by Inhibiting Wnt/beta-Catenin Pathway. PubMed, 53(1), 21–29. https://pubmed.ncbi.nlm.nih.gov/36889779

How many times has this paper been cited?

5 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Linbo Zhu, Hong Shi, Pengfei Li, Pengbin Zhang.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.